Blackwell Captive Solutions has announced a partnership with advanced diagnostic testing and personalised preventive health solutions provider Cygenex, which will become a part of B.Well Edge, Blackwell’s portfolio of solutions designed to help employers manage healthcare costs and improve outcomes. Cygenex provides advanced diagnostic testing and an early detection risk platform, designed to aid clinicians, employers, and employees in identifying health risks before they escalate into claims. President of Blackwell Captive Solutions, Scott Bryne, suggests: “Cygenex’s expertise in understanding healthcare and genetic risks adds an important layer of precision and preventive insight.” Moreover, Charles Clark, Cygenex’s CEO and CTO, views the partnership as allowing the company “to deliver our solutions within a forward-thinking captive model that prioritises innovation, risk management, and better outcomes for employees”. Cygenex will be available to all Blackwell members as an optional buy-up solution.
